A Comparative clinical study on the efficacy of Bhoomyamlaki Churna and Chandana Churna in the management of Asrigdara w.s.r to Menorrhagia and Metrorrhagia
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Duration of Menstrual Bleeding
研究概览
简要总结
The prevalence of heavy menstrual bleeding in women of reproductive age is 37.9%. Quality of life (QOL) of women with these disorders is compromised. Asrigdara is the common gynecological problem affecting her day to day activities. This leads to other diseases like anemia etc. Bhoomyamlaki Churna and Chandana Churna formulation has been selected to study the efficacy of both drug in the management of asrigdara. The aim of this study is to establish an cost effective , harmless Ayurvedic medication for the treatment of Asrigdara
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 16.00 Year(s) 至 45.00 Year(s)(—)
- 性别
- Female
入选标准
- •The patients having classical symptoms of Asrigdara as per the classical references will be selected.
排除标准
- •Patients giving history of recent delivery or abortion.
- •Patients having infections such as candidiasis, trichomonaliasis or any other form of vulvo-vaginitis and pelvic congestion.
- •Patients having systemic and other disorders like Diabetes, TB, Hypertension etc.
- •will be excluded from the study.
- •Patients taking oral contraceptive pills.
结局指标
主要结局
Duration of Menstrual Bleeding
时间窗: 120 days
Interval between 2 menstrual cycle
时间窗: 120 days
Vedana
时间窗: 120 days
次要结局
- CBC(BT CT)
研究者
Dr Yashi Joshi
Mansarovar Ayurvedic Medical College Hospital and Research Centre
